FDA: Class I Recall for Medtronic’s Physio-Control Defibs

MassDevice -- The Food & Drug Administration slapped Medtronic Inc. (NYSE:MDT) subsidiary Physio-Control Inc. with a Class I recall of its LifePak 20/20e defibrillators, after the company declared a "field correction" for a battery problem last week.